ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Eisai seeks EMA approval for Fycompa to treat epilepsy in paediatrics
February 15, 2019Eisai has submitted an application to the European Medicines Agency (EMA) seeking approval for the use of its Fycompa (perampanel) medicine to treat paediatric patients suffering with epilepsy.... -
Eisai to present latest data on Perampanel at AES annual meeting
November 23, 2018It is available in tablet form to be taken once daily, and a new oral suspension formulation has been approved and is being marketed in the United States -
Eisai Pharma to cater to the Japanese market
August 23, 2017Launches new anti-epileptic drug Fycompa (perampanel) in India
Pharma Sources Insight January 2025
